Form 4: Opus Genetics CFO Nirav S. Jhaveri Reports Stock Disposal
SEC Form 4 Filing
Nirav S. Jhaveri, CFO of Opus Genetics, Inc., reported the disposal of 8,207 shares of common stock on February 13, 2025.
Summary
- On February 13, 2025, Nirav S. Jhaveri, the Chief Financial Officer of Opus Genetics, Inc., disposed of 8,207 shares of common stock.
- The transaction was reported on February 18, 2025.
- Following the transaction, Jhaveri directly owns 141,793 shares of Opus Genetics, Inc.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock transaction. The sentiment is neither positive nor negative as it simply reports a transaction.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of key personnel.
Stakeholder Impact
- The disposal of shares by a key executive could be perceived negatively by some investors, although the impact is likely minimal given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 02/13/2025 | Date of transaction: Disposal of 8,207 shares of common stock. |
| 02/18/2025 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.